Companies/Seer, Inc.

Company profile

Seer, Inc.

NASDAQ: SEER · Healthcare · Biotechnology

PublicHQ Redwood City, CA · San MateoCIK 0001726445Reports USD

#571 of 1,394 Healthcare companies by revenue63rd-percentile growth

EA Score

49D

FH 54DQ 46GM 42SS 51

v0.1 · 65/100 weight · provisional

↑ balance-sheet leverage, workforce scale · ↓ growth stability, listing tenure

Methodology →

Revenue TTM

$14.7M

Rev growth YoY (TTM)

-2.8%

Net income (FY)

-$73.6M

Employees

134

Market cap

$89.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$16.6M$16.6M2025

Net income-$73.6M-$73.6M2025

Operating income-$78.0M-$78.0M2025

Total assets$296.1M$296.1M2025

Liabilities$36.8M$36.8M2025

Equity$259.3M$259.3M2025

Revenue trend

FY2021 – FY2025 · USD

$656.0k

FY21

$6.6M

FY21

$15.5M

FY22

$16.7M

FY23

$14.2M

FY24

$16.6M

FY25

Revenue by segment

Filed disclosures · FY2023

By product

Grant100%

By geography

Not disclosed.

The read

Seer, Inc. booked $16.6M in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -444.0% net margin.

Peers · Healthcare

Lixte Biotechnology Holdings, Inc.41D Kalaris Therapeutics Inc30D Neonc Technologies Holdings, Inc.10D MAIA Biotechnology, Inc.34D

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B87A Gilead Sciences, Inc.$29.4B87A Robinhood Markets, Inc.$4.5B67B Equinix, Inc.$9.2B73B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D

Key facts

CEOOmid C. Farokhzad

SectorHealthcare

IndustryBiotechnology

HeadquartersRedwood City, CA

ExchangeNASDAQ: SEER

Employees134

IPO date2020-12-04

Latest filings

8-K2026-07-02 8-K2026-05-22 10-Q2026-05-13 8-K2026-05-13 8-K2026-05-04 8-K2026-04-27 8-K2026-04-13 8-K2026-03-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.